STAT1 and Hepatic fibrosis: Inhibiting liver fibrosis and cirrhosis by mediatingCCR2 -STAT1/NF-κB/ERK pathway;Restraining the circulating Ly6C+ monocytes andmacrophages derived from liver monocytes